📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Establishment and Characterization of an Epstein-Barr Virus-positive Cell Line from a Non-keratinizing Differentiated Primary Nasopharyngeal Carcinoma. (2024)

First Author: Chai AWY

Attributed to: Mechanism-guided drug repurposing to accelerate the development of novel therapies for oral squamous cell carcinoma (OSCC) funded by Newton Fund

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/2767-9764.crc-23-0341

PubMed Identifier: 38358347

Publication URI: http://europepmc.org/abstract/MED/38358347

Type: Journal Article/Review

Volume: 4

Parent Publication: Cancer research communications

Issue: 3

ISSN: 2767-9764